These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12974760)

  • 1. Biclonal expansion of T cells infected with monoclonal Epstein-Barr virus (EBV) in a patient with chronic, active EBV infection.
    Toyabe S; Harada W; Uchiyama M
    Clin Exp Immunol; 2003 Oct; 134(1):92-7. PubMed ID: 12974760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restricted diversification of T-cells in chronic active Epstein-Barr virus infection: potential inclination to T-lymphoproliferative disease.
    Ohga S; Kimura N; Takada H; Nagano M; Ohshima K; Nomura A; Muraoka K; Take H; Yamamori S; Hara T
    Am J Hematol; 1999 May; 61(1):26-33. PubMed ID: 10331508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
    Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
    J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
    Kimura H
    Rev Med Virol; 2006; 16(4):251-61. PubMed ID: 16791843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.
    Kasahara Y; Yachie A; Takei K; Kanegane C; Okada K; Ohta K; Seki H; Igarashi N; Maruhashi K; Katayama K; Katoh E; Terao G; Sakiyama Y; Koizumi S
    Blood; 2001 Sep; 98(6):1882-8. PubMed ID: 11535525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
    Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
    Kato S; Miyata T; Takata K; Shimada S; Ito Y; Tomita A; Elsayed AA; Takahashi E; Asano N; Kinoshita T; Kimura H; Nakamura S
    Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-associated T-cell lymphoproliferative disorder affecting skin and lung in an elderly patient.
    Hoshino T; Tatsuno K; Shimauchi T; Okada S; Ito T; Ono T; Ohshima K; Tokura Y
    J Dermatol; 2014 Sep; 41(9):837-40. PubMed ID: 25109697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy.
    Adhikary D; Behrends U; Boerschmann H; Pfünder A; Burdach S; Moosmann A; Witter K; Bornkamm GW; Mautner J
    PLoS One; 2007 Jul; 2(7):e583. PubMed ID: 17611619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells.
    Imadome K; Yajima M; Arai A; Nakazawa A; Kawano F; Ichikawa S; Shimizu N; Yamamoto N; Morio T; Ohga S; Nakamura H; Ito M; Miura O; Komano J; Fujiwara S
    PLoS Pathog; 2011 Oct; 7(10):e1002326. PubMed ID: 22028658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of virus-specific CD4+ T cells in the control of Epstein-Barr virus infection.
    Mautner J; Bornkamm GW
    Eur J Cell Biol; 2012 Jan; 91(1):31-5. PubMed ID: 21458882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection.
    Ohga S; Nomura A; Takada H; Tanaka T; Furuno K; Takahata Y; Kinukawa N; Fukushima N; Imai S; Hara T
    J Med Virol; 2004 Nov; 74(3):449-58. PubMed ID: 15368517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal expansion of multiphenotypic Epstein-Barr virus-infected lymphocytes in chronic active Epstein-Barr virus infection.
    Endo R; Yoshioka M; Ebihara T; Ishiguro N; Kikuta H; Kobayashi K
    Med Hypotheses; 2004; 63(4):582-7. PubMed ID: 15325000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes.
    Bräuninger A; Spieker T; Mottok A; Baur AS; Küppers R; Hansmann ML
    Eur J Immunol; 2003 Jun; 33(6):1593-602. PubMed ID: 12778477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential chemokine, chemokine receptor and cytokine expression in Epstein-Barr virus-associated lymphoproliferative diseases.
    Ohshima K; Karube K; Hamasaki M; Tutiya T; Yamaguchi T; Suefuji H; Suzuki K; Suzumiya J; Ohga S; Kikuchi M
    Leuk Lymphoma; 2003 Aug; 44(8):1367-78. PubMed ID: 12952231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus nuclear antigen 1-specific CD4+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells.
    Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
    Cancer Sci; 2008 Aug; 99(8):1633-42. PubMed ID: 18754877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mouse xenotransplantation model of EBV-T/NK-LPD and the application of the mouse model.
    Imadome K
    Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(6):433-41. PubMed ID: 24390103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymphocytic Clonal Expansion in Adult Patients with Epstein-Barr Virus-Associated Lymphoproliferative Disease].
    Zhong FL; Zhang HY; Zhang Q; Feng J; Zhang WL; Xu L; Xu HC; Wen JJ; Meng QX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1658-1663. PubMed ID: 29262893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
    Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
    Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of skin blister fluids from children with Epstein-Barr virus-associated lymphoproliferative disease.
    Wada T; Toma T; Miyazawa H; Koizumi E; Shirahashi T; Matsuda Y; Yachie A
    J Dermatol; 2018 Apr; 45(4):444-449. PubMed ID: 29352500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.